$MPLN
MultiPlan Corp

2024 Q3 Form 10-Q Financial Statement

#000179322924000106 Filed on August 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $230.5M $233.5M
YoY Change -5.07% -1.9%
Cost Of Revenue $60.83M $61.37M
YoY Change -0.12% 4.0%
Gross Profit $169.7M $172.1M
YoY Change -6.72% -3.84%
Gross Profit Margin 73.61% 73.72%
Selling, General & Admin $37.73M $34.55M
YoY Change 3.36% -13.08%
% of Gross Profit 22.23% 20.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $22.57M $21.81M
YoY Change 15.25% -79.13%
% of Gross Profit 13.3% 12.67%
Operating Expenses $146.3M $142.3M
YoY Change 2.86% -1.35%
Operating Profit -$338.2M -$523.9M
YoY Change -955.82% -1609.57%
Interest Expense -$80.46M -$80.32M
YoY Change -195.44% -0.68%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$418.7M -$604.2M
YoY Change 1249.68% 1208.88%
Income Tax -$27.22M -$27.52M
% Of Pretax Income
Net Earnings -$391.5M -$576.7M
YoY Change 1521.25% 1485.72%
Net Earnings / Revenue -169.83% -247.02%
Basic Earnings Per Share -$24.25 -$0.89
Diluted Earnings Per Share -$24.25 -$0.89
COMMON SHARES
Basic Shares Outstanding 645.7M shares 644.9M shares
Diluted Shares Outstanding 16.14M shares 644.7M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.60M $48.77M
YoY Change -14.51% -45.67%
Cash & Equivalents $86.60M $48.77M
Short-Term Investments
Other Short-Term Assets $1.719M $13.99M
YoY Change -85.51% -71.66%
Inventory
Prepaid Expenses
Receivables $82.13M $81.42M
Other Receivables $0.00 $0.00
Total Short-Term Assets $211.5M $192.3M
YoY Change -0.06% -8.02%
LONG-TERM ASSETS
Property, Plant & Equipment $306.4M $304.1M
YoY Change 10.67% 12.08%
Goodwill $2.403B $2.759B
YoY Change -37.24% -27.95%
Intangibles $2.367B $2.459B
YoY Change -12.96% -12.36%
Long-Term Investments
YoY Change
Other Assets $31.30M $28.38M
YoY Change 48.55% 31.94%
Total Long-Term Assets $5.108B $5.550B
YoY Change -25.39% -19.88%
TOTAL ASSETS
Total Short-Term Assets $211.5M $192.3M
Total Long-Term Assets $5.108B $5.550B
Total Assets $5.319B $5.742B
YoY Change -24.63% -19.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.55M $22.29M
YoY Change 56.55% 43.89%
Accrued Expenses $157.6M $132.5M
YoY Change 9.43% 11.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $13.25M $13.25M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $201.5M $180.8M
YoY Change 17.36% 22.68%
LONG-TERM LIABILITIES
Long-Term Debt $4.510B $4.511B
YoY Change -1.05% -2.02%
Other Long-Term Liabilities $11.68M $4.507M
YoY Change 129.1% -81.64%
Total Long-Term Liabilities $11.68M $4.507M
YoY Change 129.1% -99.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $201.5M $180.8M
Total Long-Term Liabilities $11.68M $4.507M
Total Liabilities $5.112B $5.139B
YoY Change -3.7% -4.27%
SHAREHOLDERS EQUITY
Retained Earnings -$2.007B -$1.616B
YoY Change 328.96% 264.09%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $207.6M $603.4M
YoY Change
Total Liabilities & Shareholders Equity $5.319B $5.742B
YoY Change -24.63% -19.54%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$391.5M -$576.7M
YoY Change 1521.25% 1485.72%
Depreciation, Depletion And Amortization $22.57M $21.81M
YoY Change 15.25% -79.13%
Cash From Operating Activities $72.84M $18.47M
YoY Change 1.03% 140.35%
INVESTING ACTIVITIES
Capital Expenditures $31.70M $25.44M
YoY Change 41.52% -20.47%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$31.70M -$25.44M
YoY Change 44.09% -85.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.143M -3.035M
YoY Change -91.79% -71.74%
NET CHANGE
Cash From Operating Activities 72.84M 18.47M
Cash From Investing Activities -31.70M -25.44M
Cash From Financing Activities -3.143M -3.035M
Net Change In Cash 38.00M -10.01M
YoY Change 222.03% -94.32%
FREE CASH FLOW
Cash From Operating Activities $72.84M $18.47M
Capital Expenditures $31.70M $25.44M
Free Cash Flow $41.14M -$6.974M
YoY Change -17.22% -71.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
61369000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34551000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
21811000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
85971000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-27519000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-576727000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
644679833 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233476000 usd
CY2024Q2 mpln Gain Loss On Warrants And Rights
GainLossOnWarrantsAndRights
259000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-604246000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-576727000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-574612000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1170382000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
553701000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
757403000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-523927000 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations
CY2024Q2 mpln Unbilled Fees
UnbilledFees
13709000 usd
CY2023Q4 mpln Unbilled Fees
UnbilledFees
8197000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
81129000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
551000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
644679833 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
2115000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7266000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
593000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1522000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
331000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
603364000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1788276000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4827000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
19214000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7422000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-36370000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1768520000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1709124000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12885000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3355000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
7556000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-3101000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10370000 usd
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
839000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1116416000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
603364000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1790542000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8522000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
457000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
19214000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from the Company's estimates. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions reflected in these unaudited condensed consolidated financial statements include, but are not limited to, revenue recognition, recoverability of long-lived assets, goodwill, valuation of Private Placement Warrants and Unvested Founder Shares, valuation of stock-based compensation awards and income taxes.
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233476000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
237991000 usd
us-gaap Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
<div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Interest Rate Swap Agreements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to interest rate risk on its floating-rate debt. In September 2023, the Company entered into interest rate swap agreements to effectively convert some of its floating-rate debt to a fixed-rate basis. The Company entered into these agreements to reduce the variability of the cash flows in interest payments associated with the Company’s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to apply the hedge accounting rules in accordance with authoritative guidance for the agreements entered into during the twelve months ended December 31, 2023. Changes in the fair value of interest rate swap agreements designated as cash flow hedges are recorded as a component of accumulated other comprehensive income within stockholders’ </span></div>equity and are subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects "Earnings".
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
60300000 usd
CY2024Q2 mpln Indefinite Lived Intangible Assets Net
IndefiniteLivedIntangibleAssetsNet
60300000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
63000000 usd
CY2023Q4 mpln Indefinite Lived Intangible Assets Net
IndefiniteLivedIntangibleAssetsNet
63000000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5180100000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2721535000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2458565000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5182800000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2549593000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2633207000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
3829002000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3705199000 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
516350000 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 us-gaap Goodwill
Goodwill
3312652000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3705199000 usd
CY2024Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
124157000 usd
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
553701000 usd
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q2 us-gaap Goodwill
Goodwill
2758951000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3829356000 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
516400000 usd
CY2024Q1 mpln Goodwill Impairment Loss Permanently Nondeductible Amount
GoodwillImpairmentLossPermanentlyNondeductibleAmount
490200000 usd
CY2024Q1 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
103000000 usd
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
553700000 usd
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
553700000 usd
CY2024Q2 mpln Goodwill Impairment Loss Permanently Nondeductible Amount
GoodwillImpairmentLossPermanentlyNondeductibleAmount
522100000 usd
CY2024Q2 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
109600000 usd
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
64000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
15000 usd
CY2024Q2 mpln Long Term Debt And Finance Lease Obligations Gross
LongTermDebtAndFinanceLeaseObligationsGross
4572344000 usd
CY2023Q4 mpln Long Term Debt And Finance Lease Obligations Gross
LongTermDebtAndFinanceLeaseObligationsGross
4600030000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
13250000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
13250000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
24718000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
28164000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
23611000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
25883000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4510765000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4532733000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-259000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
763000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-389000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2394000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
553700000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1072800000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
mpln Number Of Offices
NumberOfOffices
3 office
CY2024Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1800000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1800000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10400000 usd
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-576727000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-36370000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1116416000 usd
us-gaap Net Income Loss
NetIncomeLoss
-36161000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
644679833 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
643339328 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
645499738 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
640996659 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
644679833 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
643339328 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
645499738 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
640996659 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
92000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
155000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
mpln-20240630_cal.xml Edgar Link unprocessable
0001793229-24-000106-index-headers.html Edgar Link pending
0001793229-24-000106-index.html Edgar Link pending
0001793229-24-000106.txt Edgar Link pending
0001793229-24-000106-xbrl.zip Edgar Link pending
exhibit311q22024.htm Edgar Link pending
exhibit312q22024.htm Edgar Link pending
exhibit321q22024.htm Edgar Link pending
exhibit322q22024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpln-20240630.htm Edgar Link pending
mpln-20240630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mpln-20240630_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
mpln-20240630_lab.xml Edgar Link unprocessable
mpln-20240630_pre.xml Edgar Link unprocessable
mpln-20240630_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mpln-20240630_def.xml Edgar Link unprocessable